“…beyond technical capabilities, the nature of CDMO client relationships is changing. Pharmaceutical companies are moving away from transactional engagements and seeking long-term strategic partnerships. Alignment on business strategy, culture, and operational philosophy is now a critical factor in vendor selection.
Growth was largely organic, driven by quality performance and word-of-mouth referrals. In 2023, Audax Private Equity acquired the company, bringing in an experienced management team and investing in expansion initiatives. This includes the launch of a high-speed fill line for pre-filled syringes, cartridges, and vials—enhancing Pyramid’s ability to support large-scale commercial programs." – Dirk Lange, CEO Pyramid Pharma Services
You can find the full insightful interview by Global Business Reports (GBR) with Dirk T. Lange in the following link: GBR Pyramid Interview